Arnaud Vanlander

Dr. Arnaud Vanlander

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2018 in JBIC Journal of Biological Inorganic Chemistry
Verified
Journal Article
Open access
PDF file
AVArnaud Vanlander
Arnaud Vanlander
RCR. Van Coster
R. Van Coster
Iron–sulfur clusters are evolutionarily conserved biological structures which play an important role as cofactor for multiple enzymes in eukaryotic cells. The biosynthesis pathways of the iron–sulfur clusters are located in the mitochondria and in the cytosol. The mitochondrial iron–sulfur cluster biosynthesis pathway (ISC) can be divided into at least twenty enzymatic steps. Since the description of frataxin deficiency as the cause of Friedreich’s ataxia, multiple other deficiencies in ISC biosynthesis pathway have been reported. In this paper, an overview is given of the clinical, biochemical and genetic aspects reported in humans affected by a defect in iron–sulfur cluster biosynthesis.

21 May 2018 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
EVElise Vantroys
Elise Vantroys
JSJoél EG Smet
Joél EG Smet
AVArnaud Vanlander
Arnaud Vanlander
SVSarah Vergult
Sarah Vergult
RBRuth De Bruyne
Ruth De Bruyne
RCRudy Van Coster
Rudy Van Coster
The first subjects with deficiency of mitochondrial tryptophanyl-tRNA synthetase (WARS2) were reported in 2017. Their clinical characteristics can be subdivided into three phenotypes (neonatal phenotype, severe infantile onset phenotype, Parkinson-like phenotype). Here, we report on a subject who presented with early developmental delay, motor weakness and intellectual disability and who was considered during several years as having a non-progressive encephalopathy. At the age of six years, she had an epileptic seizure which was treated with sodium valproate. In the months after treatment was started, she developed acute liver failure and severe progressive encephalopathy. Although valproate was discontinued, she died six months later. Spectrophotometric analysis of the oxidative phosphorylation complexes in liver revealed a deficient activity of complex III and low normal activities of the complexes I and IV. Activity staining in the BN-PAGE gel confirmed the low activities of complex I, III and IV and, in addition, showed the presence of a subcomplex of complex V. Histochemically, a mosaic pattern was seen in hepatocytes after cytochrome c oxidase staining. Using Whole Exome Sequencing two known pathogenic variants were detected in WARS2 (c.797delC, p.Pro266ArgfsTer10/ c.938 A > T, p.Lys313Met). This is the first report of severe hepatopathy in a subject with WARS2 deficiency. The hepatopathy occurred soon after start of sodium valproate treatment. In the literature, valproate-induced hepatotoxicity was reported in the subjects with pathogenic mutations in POLG and TWNK. This case report illustrates that the course of the disease in the subjects with a mitochondrial defect can be non-progressive during several years. The subject reported here was first diagnosed as having cerebral palsy. Only after a mitochondriotoxic medication was started, the disease became progressive, and the diagnosis of a mitochondrial defect was made.

30 January 2022 in Cells
Verified
Journal Article
Open access
PDF file
SCSara Capiau
Sara Capiau
JSJoél EG Smet
Joél EG Smet
Boel De PaepeBoel De Paepe
Boel De Paepe
YYYILMAZ YILDIZ
YILMAZ YILDIZ
MAMutluay Arslan
Mutluay Arslan
AVArnaud Vanlander
Arnaud Vanlander
Human mitochondrial disease exhibits large variation of clinical phenotypes, even in patients with the same causative gene defect. We illustrate this heterogeneity by confronting clinical and biochemical data of two patients with the uncommon pathogenic homoplasmic NC_012920.1(MT-ATP6):m.9035T>C variant in MT-ATP6. Patient 1 presented as a toddler with severe motor and speech delay and spastic ataxia without extra-neurologic involvement. Patient 2 presented in adolescence with ataxia and ophthalmoplegia without cognitive or motor impairment. Respiratory chain complex activities were normal in cultured skin fibroblasts from both patients when calculated as ratios over citrate synthase activity. Native gels found presence of subcomplexes of complex V in fibroblast and/or skeletal muscle. Bioenergetic measurements in fibroblasts from both patients detected reduced spare respiratory capacities and altered extracellular acidification rates, revealing a switch from mitochondrial respiration to glycolysis to uphold ATP production. Thus, in contrast to the differing disease presentation, biochemical evidence of mitochondrial deficiency turned out quite similar. We conclude that biochemical analysis remains a valuable tool to confirm the genetic diagnosis of mitochondrial disease, especially in patients with new gene variants or atypical clinical presentation.

10 July 2014 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
CPClaudine De Praeter
Claudine De Praeter
AVArnaud Vanlander
Arnaud Vanlander
PVPiet Vanhaesebrouck
Piet Vanhaesebrouck
JSJoél EG Smet
Joél EG Smet
SSSara Seneca
Sara Seneca
RCRudy Van Coster
Rudy Van Coster

31 May 2018 in JBIC Journal of Biological Inorganic Chemistry
Verified
Journal Article
Open access
PDF file
AVArnaud Vanlander
Arnaud Vanlander
RCR. Van Coster
R. Van Coster
The article “Clinical and genetic aspects of defects in the mitochondrial iron–sulfur cluster synthesis pathway”, written by A. V. Vanlan